0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Ruminant Vaccines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-35J14009
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Ruminant Vaccines Market Research Report 2023
BUY CHAPTERS

Ruminant Vaccines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-35J14009
Report
October 2024
Pages:137
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Ruminant Vaccines - Market Size

The global market for Ruminant Vaccines was estimated to be worth US$ 2441 million in 2023 and is forecast to a readjusted size of US$ 3610.6 million by 2030 with a CAGR of 6.1% during the forecast period 2024-2030

Ruminant Vaccines - Market

Ruminant Vaccines - Market

Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 315%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Ruminant Vaccines, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Ruminant Vaccines by region & country, by Type, and by Application.
The Ruminant Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ruminant Vaccines.
Market Segmentation

Scope of Ruminant Vaccines - Market Report

Report Metric Details
Report Name Ruminant Vaccines - Market
Forecasted market size in 2030 US$ 3610.6 million
CAGR 6.1%
Forecasted years 2024 - 2030
Segment by Type:
  • Live Attenuated Vaccines
  • Inactivated Vaccines
  • Other
Segment by Application
  • Cattle
  • Sheep
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck, Zoetis, Boehringer Ingelheim, Ceva, CAHIC, HVRI, Ringpu Biology, Yebio, DHN, WINSUN, Elanco, Virbac, Jinyu Bio-Technology, ChengDu Tecbond, CAVAC, Kyoto Biken Laboratories, FATRO, Vaksindo
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Ruminant Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Ruminant Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Ruminant Vaccines in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Ruminant Vaccines - Market size in 2030?

Ans: The Ruminant Vaccines - Market size in 2030 will be US$ 3610.6 million.

Who are the main players in the Ruminant Vaccines - Market report?

Ans: The main players in the Ruminant Vaccines - Market are Merck, Zoetis, Boehringer Ingelheim, Ceva, CAHIC, HVRI, Ringpu Biology, Yebio, DHN, WINSUN, Elanco, Virbac, Jinyu Bio-Technology, ChengDu Tecbond, CAVAC, Kyoto Biken Laboratories, FATRO, Vaksindo

What are the Application segmentation covered in the Ruminant Vaccines - Market report?

Ans: The Applications covered in the Ruminant Vaccines - Market report are Cattle, Sheep, Other

What are the Type segmentation covered in the Ruminant Vaccines - Market report?

Ans: The Types covered in the Ruminant Vaccines - Market report are Live Attenuated Vaccines, Inactivated Vaccines, Other

1 Market Overview
1.1 Ruminant Vaccines Product Introduction
1.2 Global Ruminant Vaccines Market Size Forecast
1.2.1 Global Ruminant Vaccines Sales Value (2019-2030)
1.2.2 Global Ruminant Vaccines Sales Volume (2019-2030)
1.2.3 Global Ruminant Vaccines Sales Price (2019-2030)
1.3 Ruminant Vaccines Market Trends & Drivers
1.3.1 Ruminant Vaccines Industry Trends
1.3.2 Ruminant Vaccines Market Drivers & Opportunity
1.3.3 Ruminant Vaccines Market Challenges
1.3.4 Ruminant Vaccines Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Ruminant Vaccines Players Revenue Ranking (2023)
2.2 Global Ruminant Vaccines Revenue by Company (2019-2024)
2.3 Global Ruminant Vaccines Players Sales Volume Ranking (2023)
2.4 Global Ruminant Vaccines Sales Volume by Company Players (2019-2024)
2.5 Global Ruminant Vaccines Average Price by Company (2019-2024)
2.6 Key Manufacturers Ruminant Vaccines Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Ruminant Vaccines Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Ruminant Vaccines
2.9 Ruminant Vaccines Market Competitive Analysis
2.9.1 Ruminant Vaccines Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Ruminant Vaccines Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ruminant Vaccines as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Live Attenuated Vaccines
3.1.2 Inactivated Vaccines
3.1.3 Other
3.2 Global Ruminant Vaccines Sales Value by Type
3.2.1 Global Ruminant Vaccines Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Ruminant Vaccines Sales Value, by Type (2019-2030)
3.2.3 Global Ruminant Vaccines Sales Value, by Type (%) (2019-2030)
3.3 Global Ruminant Vaccines Sales Volume by Type
3.3.1 Global Ruminant Vaccines Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Ruminant Vaccines Sales Volume, by Type (2019-2030)
3.3.3 Global Ruminant Vaccines Sales Volume, by Type (%) (2019-2030)
3.4 Global Ruminant Vaccines Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Cattle
4.1.2 Sheep
4.1.3 Other
4.2 Global Ruminant Vaccines Sales Value by Application
4.2.1 Global Ruminant Vaccines Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Ruminant Vaccines Sales Value, by Application (2019-2030)
4.2.3 Global Ruminant Vaccines Sales Value, by Application (%) (2019-2030)
4.3 Global Ruminant Vaccines Sales Volume by Application
4.3.1 Global Ruminant Vaccines Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Ruminant Vaccines Sales Volume, by Application (2019-2030)
4.3.3 Global Ruminant Vaccines Sales Volume, by Application (%) (2019-2030)
4.4 Global Ruminant Vaccines Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Ruminant Vaccines Sales Value by Region
5.1.1 Global Ruminant Vaccines Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Ruminant Vaccines Sales Value by Region (2019-2024)
5.1.3 Global Ruminant Vaccines Sales Value by Region (2025-2030)
5.1.4 Global Ruminant Vaccines Sales Value by Region (%), (2019-2030)
5.2 Global Ruminant Vaccines Sales Volume by Region
5.2.1 Global Ruminant Vaccines Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Ruminant Vaccines Sales Volume by Region (2019-2024)
5.2.3 Global Ruminant Vaccines Sales Volume by Region (2025-2030)
5.2.4 Global Ruminant Vaccines Sales Volume by Region (%), (2019-2030)
5.3 Global Ruminant Vaccines Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Ruminant Vaccines Sales Value, 2019-2030
5.4.2 North America Ruminant Vaccines Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Ruminant Vaccines Sales Value, 2019-2030
5.5.2 Europe Ruminant Vaccines Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Ruminant Vaccines Sales Value, 2019-2030
5.6.2 Asia Pacific Ruminant Vaccines Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Ruminant Vaccines Sales Value, 2019-2030
5.7.2 South America Ruminant Vaccines Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Ruminant Vaccines Sales Value, 2019-2030
5.8.2 Middle East & Africa Ruminant Vaccines Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Ruminant Vaccines Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Ruminant Vaccines Sales Value
6.2.1 Key Countries/Regions Ruminant Vaccines Sales Value, 2019-2030
6.2.2 Key Countries/Regions Ruminant Vaccines Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Ruminant Vaccines Sales Value, 2019-2030
6.3.2 United States Ruminant Vaccines Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Ruminant Vaccines Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Ruminant Vaccines Sales Value, 2019-2030
6.4.2 Europe Ruminant Vaccines Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Ruminant Vaccines Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Ruminant Vaccines Sales Value, 2019-2030
6.5.2 China Ruminant Vaccines Sales Value by Type (%), 2023 VS 2030
6.5.3 China Ruminant Vaccines Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Ruminant Vaccines Sales Value, 2019-2030
6.6.2 Japan Ruminant Vaccines Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Ruminant Vaccines Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Ruminant Vaccines Sales Value, 2019-2030
6.7.2 South Korea Ruminant Vaccines Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Ruminant Vaccines Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Ruminant Vaccines Sales Value, 2019-2030
6.8.2 Southeast Asia Ruminant Vaccines Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Ruminant Vaccines Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Ruminant Vaccines Sales Value, 2019-2030
6.9.2 India Ruminant Vaccines Sales Value by Type (%), 2023 VS 2030
6.9.3 India Ruminant Vaccines Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Merck
7.1.1 Merck Company Information
7.1.2 Merck Introduction and Business Overview
7.1.3 Merck Ruminant Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Merck Ruminant Vaccines Product Offerings
7.1.5 Merck Recent Development
7.2 Zoetis
7.2.1 Zoetis Company Information
7.2.2 Zoetis Introduction and Business Overview
7.2.3 Zoetis Ruminant Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Zoetis Ruminant Vaccines Product Offerings
7.2.5 Zoetis Recent Development
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Company Information
7.3.2 Boehringer Ingelheim Introduction and Business Overview
7.3.3 Boehringer Ingelheim Ruminant Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Boehringer Ingelheim Ruminant Vaccines Product Offerings
7.3.5 Boehringer Ingelheim Recent Development
7.4 Ceva
7.4.1 Ceva Company Information
7.4.2 Ceva Introduction and Business Overview
7.4.3 Ceva Ruminant Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Ceva Ruminant Vaccines Product Offerings
7.4.5 Ceva Recent Development
7.5 CAHIC
7.5.1 CAHIC Company Information
7.5.2 CAHIC Introduction and Business Overview
7.5.3 CAHIC Ruminant Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.5.4 CAHIC Ruminant Vaccines Product Offerings
7.5.5 CAHIC Recent Development
7.6 HVRI
7.6.1 HVRI Company Information
7.6.2 HVRI Introduction and Business Overview
7.6.3 HVRI Ruminant Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.6.4 HVRI Ruminant Vaccines Product Offerings
7.6.5 HVRI Recent Development
7.7 Ringpu Biology
7.7.1 Ringpu Biology Company Information
7.7.2 Ringpu Biology Introduction and Business Overview
7.7.3 Ringpu Biology Ruminant Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Ringpu Biology Ruminant Vaccines Product Offerings
7.7.5 Ringpu Biology Recent Development
7.8 Yebio
7.8.1 Yebio Company Information
7.8.2 Yebio Introduction and Business Overview
7.8.3 Yebio Ruminant Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Yebio Ruminant Vaccines Product Offerings
7.8.5 Yebio Recent Development
7.9 DHN
7.9.1 DHN Company Information
7.9.2 DHN Introduction and Business Overview
7.9.3 DHN Ruminant Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.9.4 DHN Ruminant Vaccines Product Offerings
7.9.5 DHN Recent Development
7.10 WINSUN
7.10.1 WINSUN Company Information
7.10.2 WINSUN Introduction and Business Overview
7.10.3 WINSUN Ruminant Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.10.4 WINSUN Ruminant Vaccines Product Offerings
7.10.5 WINSUN Recent Development
7.11 Elanco
7.11.1 Elanco Company Information
7.11.2 Elanco Introduction and Business Overview
7.11.3 Elanco Ruminant Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Elanco Ruminant Vaccines Product Offerings
7.11.5 Elanco Recent Development
7.12 Virbac
7.12.1 Virbac Company Information
7.12.2 Virbac Introduction and Business Overview
7.12.3 Virbac Ruminant Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Virbac Ruminant Vaccines Product Offerings
7.12.5 Virbac Recent Development
7.13 Jinyu Bio-Technology
7.13.1 Jinyu Bio-Technology Company Information
7.13.2 Jinyu Bio-Technology Introduction and Business Overview
7.13.3 Jinyu Bio-Technology Ruminant Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Jinyu Bio-Technology Ruminant Vaccines Product Offerings
7.13.5 Jinyu Bio-Technology Recent Development
7.14 ChengDu Tecbond
7.14.1 ChengDu Tecbond Company Information
7.14.2 ChengDu Tecbond Introduction and Business Overview
7.14.3 ChengDu Tecbond Ruminant Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.14.4 ChengDu Tecbond Ruminant Vaccines Product Offerings
7.14.5 ChengDu Tecbond Recent Development
7.15 CAVAC
7.15.1 CAVAC Company Information
7.15.2 CAVAC Introduction and Business Overview
7.15.3 CAVAC Ruminant Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.15.4 CAVAC Ruminant Vaccines Product Offerings
7.15.5 CAVAC Recent Development
7.16 Kyoto Biken Laboratories
7.16.1 Kyoto Biken Laboratories Company Information
7.16.2 Kyoto Biken Laboratories Introduction and Business Overview
7.16.3 Kyoto Biken Laboratories Ruminant Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Kyoto Biken Laboratories Ruminant Vaccines Product Offerings
7.16.5 Kyoto Biken Laboratories Recent Development
7.17 FATRO
7.17.1 FATRO Company Information
7.17.2 FATRO Introduction and Business Overview
7.17.3 FATRO Ruminant Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.17.4 FATRO Ruminant Vaccines Product Offerings
7.17.5 FATRO Recent Development
7.18 Vaksindo
7.18.1 Vaksindo Company Information
7.18.2 Vaksindo Introduction and Business Overview
7.18.3 Vaksindo Ruminant Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Vaksindo Ruminant Vaccines Product Offerings
7.18.5 Vaksindo Recent Development
8 Industry Chain Analysis
8.1 Ruminant Vaccines Industrial Chain
8.2 Ruminant Vaccines Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Ruminant Vaccines Sales Model
8.5.2 Sales Channel
8.5.3 Ruminant Vaccines Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Ruminant Vaccines Market Trends
    Table 2. Ruminant Vaccines Market Drivers & Opportunity
    Table 3. Ruminant Vaccines Market Challenges
    Table 4. Ruminant Vaccines Market Restraints
    Table 5. Global Ruminant Vaccines Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Ruminant Vaccines Revenue Market Share by Company (2019-2024)
    Table 7. Global Ruminant Vaccines Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Ruminant Vaccines Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Ruminant Vaccines Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Ruminant Vaccines Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Ruminant Vaccines Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Ruminant Vaccines
    Table 13. Global Ruminant Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ruminant Vaccines as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Ruminant Vaccines Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Ruminant Vaccines Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Ruminant Vaccines Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Ruminant Vaccines Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Ruminant Vaccines Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Ruminant Vaccines Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Ruminant Vaccines Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Ruminant Vaccines Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Ruminant Vaccines Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Ruminant Vaccines Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Ruminant Vaccines Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Ruminant Vaccines Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Ruminant Vaccines Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Ruminant Vaccines Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Ruminant Vaccines Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Ruminant Vaccines Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Ruminant Vaccines Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Ruminant Vaccines Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Ruminant Vaccines Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Ruminant Vaccines Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Ruminant Vaccines Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Ruminant Vaccines Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Ruminant Vaccines Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Ruminant Vaccines Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Ruminant Vaccines Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Ruminant Vaccines Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Ruminant Vaccines Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Ruminant Vaccines Sales Value by Region (2019-2024) & (%)
    Table 44. Global Ruminant Vaccines Sales Value by Region (2025-2030) & (%)
    Table 45. Global Ruminant Vaccines Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Ruminant Vaccines Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Ruminant Vaccines Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Ruminant Vaccines Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Ruminant Vaccines Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Ruminant Vaccines Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Ruminant Vaccines Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Ruminant Vaccines Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Ruminant Vaccines Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Ruminant Vaccines Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Ruminant Vaccines Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Ruminant Vaccines Sales Volume, (2025-2030) & (K Units)
    Table 57. Merck Company Information
    Table 58. Merck Introduction and Business Overview
    Table 59. Merck Ruminant Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Merck Ruminant Vaccines Product Offerings
    Table 61. Merck Recent Development
    Table 62. Zoetis Company Information
    Table 63. Zoetis Introduction and Business Overview
    Table 64. Zoetis Ruminant Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Zoetis Ruminant Vaccines Product Offerings
    Table 66. Zoetis Recent Development
    Table 67. Boehringer Ingelheim Company Information
    Table 68. Boehringer Ingelheim Introduction and Business Overview
    Table 69. Boehringer Ingelheim Ruminant Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Boehringer Ingelheim Ruminant Vaccines Product Offerings
    Table 71. Boehringer Ingelheim Recent Development
    Table 72. Ceva Company Information
    Table 73. Ceva Introduction and Business Overview
    Table 74. Ceva Ruminant Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Ceva Ruminant Vaccines Product Offerings
    Table 76. Ceva Recent Development
    Table 77. CAHIC Company Information
    Table 78. CAHIC Introduction and Business Overview
    Table 79. CAHIC Ruminant Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. CAHIC Ruminant Vaccines Product Offerings
    Table 81. CAHIC Recent Development
    Table 82. HVRI Company Information
    Table 83. HVRI Introduction and Business Overview
    Table 84. HVRI Ruminant Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. HVRI Ruminant Vaccines Product Offerings
    Table 86. HVRI Recent Development
    Table 87. Ringpu Biology Company Information
    Table 88. Ringpu Biology Introduction and Business Overview
    Table 89. Ringpu Biology Ruminant Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Ringpu Biology Ruminant Vaccines Product Offerings
    Table 91. Ringpu Biology Recent Development
    Table 92. Yebio Company Information
    Table 93. Yebio Introduction and Business Overview
    Table 94. Yebio Ruminant Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Yebio Ruminant Vaccines Product Offerings
    Table 96. Yebio Recent Development
    Table 97. DHN Company Information
    Table 98. DHN Introduction and Business Overview
    Table 99. DHN Ruminant Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. DHN Ruminant Vaccines Product Offerings
    Table 101. DHN Recent Development
    Table 102. WINSUN Company Information
    Table 103. WINSUN Introduction and Business Overview
    Table 104. WINSUN Ruminant Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. WINSUN Ruminant Vaccines Product Offerings
    Table 106. WINSUN Recent Development
    Table 107. Elanco Company Information
    Table 108. Elanco Introduction and Business Overview
    Table 109. Elanco Ruminant Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Elanco Ruminant Vaccines Product Offerings
    Table 111. Elanco Recent Development
    Table 112. Virbac Company Information
    Table 113. Virbac Introduction and Business Overview
    Table 114. Virbac Ruminant Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Virbac Ruminant Vaccines Product Offerings
    Table 116. Virbac Recent Development
    Table 117. Jinyu Bio-Technology Company Information
    Table 118. Jinyu Bio-Technology Introduction and Business Overview
    Table 119. Jinyu Bio-Technology Ruminant Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. Jinyu Bio-Technology Ruminant Vaccines Product Offerings
    Table 121. Jinyu Bio-Technology Recent Development
    Table 122. ChengDu Tecbond Company Information
    Table 123. ChengDu Tecbond Introduction and Business Overview
    Table 124. ChengDu Tecbond Ruminant Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. ChengDu Tecbond Ruminant Vaccines Product Offerings
    Table 126. ChengDu Tecbond Recent Development
    Table 127. CAVAC Company Information
    Table 128. CAVAC Introduction and Business Overview
    Table 129. CAVAC Ruminant Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 130. CAVAC Ruminant Vaccines Product Offerings
    Table 131. CAVAC Recent Development
    Table 132. Kyoto Biken Laboratories Company Information
    Table 133. Kyoto Biken Laboratories Introduction and Business Overview
    Table 134. Kyoto Biken Laboratories Ruminant Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 135. Kyoto Biken Laboratories Ruminant Vaccines Product Offerings
    Table 136. Kyoto Biken Laboratories Recent Development
    Table 137. FATRO Company Information
    Table 138. FATRO Introduction and Business Overview
    Table 139. FATRO Ruminant Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 140. FATRO Ruminant Vaccines Product Offerings
    Table 141. FATRO Recent Development
    Table 142. Vaksindo Company Information
    Table 143. Vaksindo Introduction and Business Overview
    Table 144. Vaksindo Ruminant Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 145. Vaksindo Ruminant Vaccines Product Offerings
    Table 146. Vaksindo Recent Development
    Table 147. Key Raw Materials Lists
    Table 148. Raw Materials Key Suppliers Lists
    Table 149. Ruminant Vaccines Downstream Customers
    Table 150. Ruminant Vaccines Distributors List
    Table 151. Research Programs/Design for This Report
    Table 152. Key Data Information from Secondary Sources
    Table 153. Key Data Information from Primary Sources
List of Figures
    Figure 1. Ruminant Vaccines Product Picture
    Figure 2. Global Ruminant Vaccines Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Ruminant Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Ruminant Vaccines Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Ruminant Vaccines Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Ruminant Vaccines Report Years Considered
    Figure 7. Global Ruminant Vaccines Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Ruminant Vaccines Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Ruminant Vaccines Revenue in 2023
    Figure 10. Ruminant Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Live Attenuated Vaccines Picture
    Figure 12. Inactivated Vaccines Picture
    Figure 13. Other Picture
    Figure 14. Global Ruminant Vaccines Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Ruminant Vaccines Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Global Ruminant Vaccines Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 17. Global Ruminant Vaccines Sales Volume Market Share by Type, 2023 & 2030
    Figure 18. Global Ruminant Vaccines Price by Type (2019-2030) & (US$/Unit)
    Figure 19. Product Picture of Cattle
    Figure 20. Product Picture of Sheep
    Figure 21. Product Picture of Other
    Figure 22. Global Ruminant Vaccines Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 23. Global Ruminant Vaccines Sales Value Market Share by Application, 2023 & 2030
    Figure 24. Global Ruminant Vaccines Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 25. Global Ruminant Vaccines Sales Volume Market Share by Application, 2023 & 2030
    Figure 26. Global Ruminant Vaccines Price by Application (2019-2030) & (US$/Unit)
    Figure 27. North America Ruminant Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 28. North America Ruminant Vaccines Sales Value by Country (%), 2023 VS 2030
    Figure 29. Europe Ruminant Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 30. Europe Ruminant Vaccines Sales Value by Country (%), 2023 VS 2030
    Figure 31. Asia Pacific Ruminant Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Ruminant Vaccines Sales Value by Country (%), 2023 VS 2030
    Figure 33. South America Ruminant Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 34. South America Ruminant Vaccines Sales Value by Country (%), 2023 VS 2030
    Figure 35. Middle East & Africa Ruminant Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 36. Middle East & Africa Ruminant Vaccines Sales Value by Country (%), 2023 VS 2030
    Figure 37. Key Countries/Regions Ruminant Vaccines Sales Value (%), (2019-2030)
    Figure 38. Key Countries/Regions Ruminant Vaccines Sales Volume (%), (2019-2030)
    Figure 39. United States Ruminant Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 40. United States Ruminant Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 41. United States Ruminant Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 42. Europe Ruminant Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Europe Ruminant Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 44. Europe Ruminant Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 45. China Ruminant Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 46. China Ruminant Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 47. China Ruminant Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 48. Japan Ruminant Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Japan Ruminant Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 50. Japan Ruminant Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 51. South Korea Ruminant Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 52. South Korea Ruminant Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 53. South Korea Ruminant Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 54. Southeast Asia Ruminant Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 55. Southeast Asia Ruminant Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 56. Southeast Asia Ruminant Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 57. India Ruminant Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 58. India Ruminant Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 59. India Ruminant Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 60. Ruminant Vaccines Industrial Chain
    Figure 61. Ruminant Vaccines Manufacturing Cost Structure
    Figure 62. Channels of Distribution (Direct Sales, and Distribution)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS